NIH-funded research R15 grant

Hearing and sound‑localization problems in Fragile X syndrome

Official title: Myelination Deficits Underlying Auditory Issues in Fragile X Syndrome

Funded at Oklahoma State University Stillwater · NIH-11125625 · Data updated 2026-11-12

This work looks at whether reduced myelin (nerve insulation) causes trouble hearing and locating sounds in people with Fragile X syndrome.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionOklahoma State University Stillwater
NIH-funded
Lab location1 site (Stillwater, United States)
Project startSeptember 9, 2021
Project endJuly 31, 2028
Funding year2025
Award (this year)$444,238
NIH project number2R15HD105231-02A1
Project IDNIH-11125625 on NIH RePORTER

Who could benefit from this research

Could help

People with Fragile X syndrome and caregivers concerned about listening or sound‑sensitivity problems would be most relevant to this line of research and any future human studies.

Less likely to help

People whose hearing difficulties stem from ear‑level damage (for example chronic middle‑ear disease or cochlear injury) rather than brainstem myelination are less likely to benefit directly.

What this research studies

Researchers will use mice that model Fragile X to study whether the insulation (myelin) around hearing nerve fibers in the brainstem is thinner or altered. They will use genetic methods plus microscopy to examine myelin structure, record auditory brainstem responses (ABRs) to measure signal timing, and run startle‑response tests to gauge hearing behavior. The team aims to connect anatomical myelin defects with slowed or changed sound processing that could explain difficulties in noisy environments. Though this project is lab‑based in animals, the findings are intended to guide future human screening or treatment approaches for Fragile X and related autism‑spectrum auditory problems.

Why it matters

Potential benefit: Could identify a measurable brain change behind hearing problems in Fragile X and point toward new screening or treatment strategies.

How similar studies have gone: Earlier animal work, including the team's prior R15, found thinner myelin and altered auditory brainstem responses in Fragile X mice, but translating these results to human patients has not yet been demonstrated.

Where this research is happening

  • Oklahoma State University Stillwater
    Stillwater, United States
    Active

Researchers

  • Principal investigator: Mccullagh, Elizabeth Anne — Oklahoma State University Stillwater
  • Study coordinator: Mccullagh, Elizabeth Anne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.